evidence: The researchers also noted that the health risks associated with COVID-19 infection are much higher than those associated with vaccination. "[M]ultiple studies demonstrated higher risk of developing the events under study, such as [Guillain-Barré] syndrome), myocarditis, or ADEM, following SARS-CoV-2 infection than vaccination," they wrote. For example, the risk of experiencing a neurological event after a COVID-19 infection is 617-times higher than it is after a COVID-19 vaccination. The risk of myocarditis and Guillain-Barré are also much higher after a COVID-19 infection than a vaccination. Overall, "[t]he odds of all of these adverse events is still much, much higher when infected with SARS-CoV-2 (COVID-19), so getting vaccinated is still by far the safer choice," said Jacob Glanville, CEO of the biotechnology company Centivax, who was not involved in the study. (Choi, The Hill, 2/19; Johnson, Forbes, 2/19; Gale, Bloomberg, 2/18; Choi/Weixel, The Hill, 2/20)